S&P cuts Boston Scientific outlook to negative on franchise pressures
Alpha Vantage · Yahoo Finance Singapore · · AI-summarised by FinFlash
S&P Global Ratings revised Boston Scientific's outlook to negative from stable, citing deepening commercial headwinds in core product franchises and the burden of its pending Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.Understand the context